World of DTC Marketing

JULY 9, 2021

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” ” From 2016 to 2020, compensation for the 14 companies’ top executives totaled $3.2 The drug industry is driven by profits, not by patient’s needs.

Pharma 292

Pharma FDA Leads Competition 292

World of DTC Marketing

MARCH 17, 2021

Pharma has gone to court again and again to delay generic competition of biologic drugs. One company AbbVie has used the courts to stop competition of its top drug Humira. By the look of 2020’s results, he’s on the right track—and his compensation shows it. For writing that 2020 success story, CEO Albert Bourla, Ph.D.,

Pharma 186

Pharma Competition Prescription Doctors 186

pharmaphorum

JULY 22, 2022

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. ” The post Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe appeared first on.

Competition 100

Competition Pharma Marketing Patients 100

Pharmaceutical Technology

MARCH 8, 2023

These two insulin therapies have been off patent for about a decade but have a list price of about $500 for a pack of five injection pens and currently have limited competition from biosimilars. At $92 for a five-pack of injections, Rezvoglar is a 78% discount on the price of Lantus.

Competition 105

Competition Insurance Leads Marketing 105

World of DTC Marketing

MAY 26, 2021

In 2020 alone, AbbVie collected $16 billion in U.S. billion in 2020. billion in 2020. AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars. Here is the executive summary from the report. net revenue for Humira. AbbVie’s yearly U.S. AbbVie’s U.S.

Competition 180

Competition Marketing Government Patients 180

Pharma Leaders

JUNE 26, 2023

At issue is whether Forest Laboratories, which AbbVie acquired in 2020 as part of its acquisition of Allergan, conspired with six generics makers to delay competition for Bystolic by granting reverse payments in exchange for the generics companies dropping their Bystolic patent challenges for eight years.

Competition 52

Competition Pharmaceutical Healthcare Healthcare 52

European Pharmaceutical Review

JANUARY 2, 2024

Pharma pushes for UK medicine scheme revision Drug pricing was considered as the most negative emerging regulatory and macroeconomic trend, impeding growth for the industry, based on GlobalData’s 2019, 2020, 2021, and 2022 industry outlooks.

Pharma 80

Pharma Medicine Government Marketing 80

Copyright Clearance Center

MAY 16, 2023

Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries. Tom Ogier, CCC’s Director of Client Engagement and Solutions, was named a silver winner for Customer Service Executive of the Year in the 2020 Best in Biz Awards.

Competition 98

Competition Sales 98

World of DTC Marketing

JULY 27, 2022

Those health insurers, in turn, use the discounts to offer more competitive premiums in a bid to attract enrollees. In 2020, the value of these coupons totaled $14 billion. PBMs skim off a substantial share of the negotiated savings for themselves and pass the rest to insurers.

Insurance 226

Insurance Prescription Medicine Medical 226

Clarify Health

MARCH 2, 2021

The hospital strategy team anticipates and plans for changing market dynamics, competitive pressures, consumer behaviors, technological advances, evolving regulations, and macro and micro factors that impact health. For many hospitals in 2020, strategy had to take a backseat. Instead of opening new facilities [.].

Competition 52

Competition Marketing 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database. AbbVie reported a 22.7%

Sales 108

Sales Competition Pharmaceutical Pharmaceutical research 108

Medical Device Success

OCTOBER 18, 2020

Reading time: 2 – 3 minutes In January 2018 when Dominik Beck took the helm of Rudolf Riester, GmbH, he began executing a plan to put Riester in a more competitive position against its larger rivals. Then in early 2020 Covid spread across the world. Then in early 2020 Covid spread across the world.

Leads 100

Leads Doctors Competition Medical 100

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 87

Government Recruitment Medicine Competition 87

Pharmaceutical Technology

JUNE 12, 2023

GlobalData’s Internet of Things market report helps keep abreast of the latest trends in Internet of Things, market opportunity forecast and the competitive landscape. Starting at 100 in 2020, an index over 100 is more positive. Buy the report here. The overall index for internet of things in Q1 2023 was 77.

Pharmaceutical 52

Pharmaceutical Government Competition Marketing 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 85

Medicine Healthcare Healthcare Pharma 85

Pharmaceutical Technology

MAY 29, 2023

It provides forward-looking analysis of the market including market sizing up to 2026, segmentation by application, potential growth opportunities, and competitive pr Buy the report here. Starting at 100 in 2020, an index over 100 is more positive. The overall index for blockchain in Q1 2023 was 74.

Pharmaceutical 52

Pharmaceutical Competition Marketing Medicine 52

Sales Talent

JANUARY 21, 2021

Last year we concluded our 2020 Sales Hiring Forecast with the following statement. Despite COVID’s brutal impact on the economy in Q2 2020, much of its effects on employment are behind us. 2020 Sales Hiring in Review. 2020 began with an exceedingly low 3.5% In fact, the BLS reported that in December 2020 there were 1.5M

Sales 52

Sales Recruitment Marketing Competition 52

Pharmaceutical Technology

DECEMBER 5, 2022

Overall, Aurinia’s Lupkynis is expected to face tough competition from Benlysta in LN, which received FDA approval in December 2020 and EMA approval in May 2021. However, the lack of in-person administration by physicians will likely also impact patient compliance.

Food and Drug Administration 59

Food and Drug Administration Physicians Competition FDA 59

European Pharmaceutical Review

APRIL 28, 2023

Yet the EFPIA President cautioned that while the revised legislation was meant to “improve Europe’s competitiveness, the ‘net’ impact of policies set out across these proposals, in their current form, puts European competitiveness at risk.”

Pharmaceutical 86

Pharmaceutical Pharma Medicine Competition 86

Integrity Solutions

MARCH 30, 2020

Every company started 2020 with a plan—in many cases a well-thought-out and carefully crafted blueprint outlining expected progress on a month-by-month basis, complete with year-end targets for revenue, employees, products, clients and profitability. How can we differentiate our offerings more effectively from the competition?

Sales 88

Sales Competition Ethics Marketing 88

PM360

AUGUST 9, 2022

Most recently, he took over the then-called Impel NeuroPharma in May 2020—at the height of the pandemic—and since then has led the company through its first product approval, undergone an initial public offering (IPO), rebranded to Impel Pharmaceuticals, and attracted big interest from Big Pharma in its novel drug delivery technology.

Pharmaceutical 72

Pharmaceutical Physicians Pharma Competition 72

European Pharmaceutical Review

NOVEMBER 3, 2022

Competitiveness. It found in 2020, at the height of the pandemic, confidence dipped significantly, however scores have risen globally in the past two years. The US was found to be the leading country within the industry and has one of the highest growth scores in the survey’s history. Finished Dosage. Knowledge of professionals.

Pharma 82

Pharma Manufacturing Competition Pharmaceutical products 82

Infuse Medical

MAY 4, 2021

Let’s face it: 2020 changed things for a lot of business. For many companies, 2020 not only forced them to reimagine their sales experience, but it also showed sales managers the weaknesses in their overall sales process. Study Your Competition That is Crushing It. The reality is that 2020 shook up a lot of things.

Sales Strategy 52

Sales Strategy Sales Medical Sales process 52

World of DTC Marketing

OCTOBER 5, 2021

For 17 of the 20 top-selling drugs worldwide in 2020, pharmaceutical corporations made more money from U.S. Its immense power relative to most of the other stakeholders in the $3.5 trillion health care sector stems from many factors, but it begins from what it does. According to Public Citizen : U.S. In other words, the U.S.

Pharma 241

Pharma Insurance Sales Government 241

Healthcare Success

APRIL 8, 2024

As an engineering undergrad, I took a Marketing 101 class on a lark, seeking to better understand the psychology behind consumer behavior and developing products with a competitive edge. The 7 tactics of marketing can help you: Develop a competitive advantage. Promote that competitive edge with vigor. Reach a broader audience.

Marketing 112

Marketing Competition Patients Healthcare 112

Clarity Engagement Solutions

FEBRUARY 12, 2021

In 2020 most pharmaceutical companies continued their strategic planning as if by 2021 everything would be back to normal. We know of several companies that are doing great, DESPITE what 2020 threw at them. Leaving the competition in their wake. Oh no, 2021 has started and our plan is already outdated! Sounds familiar?

Healthcare 91

Healthcare Healthcare Competition Management 91

pharmaphorum

NOVEMBER 10, 2022

However, turnover fell back to $148 million in 2021, mainly as a result of strong competition from AstraZeneca and Merck & Co’s class-leading Lynparza (olaparib) – which has a much broader product label – as well as GSK’s Zejula (niraparib). With finances tight, Clovis has deferred a $1.9

Competition 57

Competition Sales Leads Marketing 57

pharmaphorum

JULY 22, 2022

The Life Sciences Competitiveness Indicators report shows that spending on life sciences R&D was £2.7 billion in 2020 – accounting for 0.12% of GDP and ranked third among the top 15 industrialised nations, behind only the US and Japan.

Government 52

Government Medicine Recruitment Competition 52

Clarivate

OCTOBER 5, 2023

Budgets and staffing are tight, competitive pressures are on the rise, and clients and business leaders are demanding more for less — without compromising quality. The importance of IP is elevated during a downturn as companies seek to bolster their revenue and gain competitive advantage.

Competition 59

Competition Management Professional Services Marketing 59

Clarivate

OCTOBER 24, 2023

For example, major joint replacement surgeries in ambulatory surgery centers (ASCs) experienced a 30% growth from 2020 to 2022, with 60% of ASC directors and surgeons expecting this trend to continue. According to Clarivate data, traditional inpatient procedures are increasingly shifting to outpatient settings.

Sales Strategy 52

Sales Strategy Marketing Sales Competition 52

pharmaphorum

JANUARY 29, 2023

The EU regulator’s Committee for Medicinal Products for Human Use (CHMP) said it will “assess the impact of these findings on the balance of benefits and risks of Adakveo” and the impact on its conditional approval, which was granted in 2020.

Competition 52

Competition Medicine FDA Marketing 52

Actando

NOVEMBER 19, 2020

Like remote engagement of our customers, remote learning has become a widely implemented experience during 2020. Many commercial team members are feeling isolated from their customers and their colleagues, and are looking for peer-to-peer learning, interactions, and even competitions to boost motivation and engagement.

Media 52

Media Competition Training 52

MedCity News

JUNE 1, 2023

Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. As of October 2020, most health plans are required to disclose costs in a machine-readable format that also includes descriptions of typically cryptic billing codes in plain-language descriptions.

Patients 118

Patients Healthcare Healthcare Electronics 118

Pharma Marketing Network

MARCH 25, 2023

With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. According to a report by Kantar Media, in 2020, spending on DTC advertising was estimated to be around $7.2 ” American Medical Association, 2020.

Pharma 52

Pharma Food and Drug Administration Prescription Pharmaceutical 52

Contrarian Sales Techniques

JANUARY 30, 2023

According to data from the Bureau of Labor Statistics, the median annual salary for medical and pharmaceutical sales representatives in 2020 was $71,840. In short, Medical sales can be a lucrative job, with a median salary of $71,840 per year and an expected growth of 3 percent from 2020 to 2030.

Medical sales 52

Medical sales Sales Medical Healthcare Provider 52

pharmaphorum

JULY 8, 2022

The move comes as Sobi’s haematology business – centred largely around a partnership with Sanofi in haemophilia therapies – has come under competitive pressure from new therapies like Roche’s Hemlibra (emicizumab).

Competition 52

Competition Prospecting Marketing Sales 52

Pharmaceutical Technology

JULY 21, 2022

In 2020, Fisher & Paykel Healthcare, a medical devices firm, made a SBTi commitment to reduce GHG emissions by 67% by 2034. This is partly because its greenhouse gases (GHG) emissions are relatively low. Aggressive strategies to maximise profits and appease investors result in prices that are unjustifiable and unaffordable by consumers.

Government 52

Government Healthcare Healthcare Pharma 52